Next report date
Report period
Q2 2024
EPS estimate
−0.17CNY
Revenue estimate
—
−278.58 MCNY
385.42 MCNY
221.07 M
Om SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD
Sektor
Bransch
VD
Ze Lin Sheng
Webbplats
Huvudkvarter
Kunshan
Employees (FY)
867
Grundat
2009
ISIN
CNE100003RP1
FIGI
BBG00PDZ4FP7
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
